TA Securities Upgrades AMWAY After Share-Price Weakness as Margins Cushion Soft Sales
C.R. Lee ·
AI-assisted, reviewed by C.R. Lee
TA Securities analyst Liew Yi Jiet upgraded Amway (Malaysia) Holdings to “Hold” from “Sell” following recent share-price weakness, although he lowered his target price to RM4.50 from RM4.67, implying 11.1% upside. The target-price adjustment reflects a revised risk-free rate assumption, with earnings forecasts unchanged.
Third-quarter core net profit edged up 1.8% QoQ to RM9.1 million, supported by earlier price adjustments and lower input costs despite weaker sales. Nine-month core earnings fell 8.8% YoY to RM27.8 million, meeting his expectations, as softer sales volumes and higher selling and administrative expenses weighed on profitability.
Liew expects cautious consumer spending to keep fourth-quarter sales challenging, while pricing adjustments and cost controls should support margins. He forecasts a gradual earnings recovery in 2027, supported by product innovation focused on healthy ageing and long-term wellbeing. The group declared a quarterly dividend of five sen per share, bringing nine-month dividends to 15 sen, unchanged year-on-year.
As of 9:26 a.m. on November 17, Amway (Malaysia) Holdings’ share price was unchanged at RM4.05.
Disclaimer: All content is AI-aggregated from public sources for informational and educational purposes only. StockTipRatings.com does not constitute investment advice. Past performance and historical statistics are no guarantee of future returns.
The call: TA on AMWAY (MALAYSIA) HOLDINGS BERHAD
- Rating
- Hold
- Target price
- RM 4.50 (from RM 4.67)
- Upside from current
- 13.9%
Liew Yi Jiet's 12-month track record
No.7 of 11 analysts at TA
- Success rate
- 54%
- Average return
- 2%
- Stocks covered
- 23
Consensus target price for AMWAY
Sign up free to see the consensus target, or read the AMWAY target price and analyst ratings.